Get 20% lifetime commission for referring investors to digrin.com
here.
JAGSONPAL PHARMACE (JAGSNPHARM.NS) Financials
JAGSNPHARM.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 2.1 billion | 400.0 million |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 1.9 billion | 360.6 million |
JAGSNPHARM.NS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 8.2 million | ? |
| 2023-09-30 | 50.9 million | 41.8 million |
| 2023-06-30 | 42.0 million | 42.0 million |
| 2023-03-31 | 39.3 million | 39.3 million |
JAGSNPHARM.NS Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | 39.6 million |
| 2023-09-30 | 74.7 million |
| 2023-06-30 | 74.8 million |
| 2023-03-31 | 56.0 million |
JAGSNPHARM.NS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 1.1 billion | 81.6 million | 93.1 million |
| 2023-06-30 | 1.1 billion | - | - |
| 2023-03-31 | 1.1 billion | 52.5 million | 60.0 million |
JAGSNPHARM.NS Shares Outstanding
JAGSNPHARM.NS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 2.3 million | - | 117.0 million | - |
| 2023-06-30 | - | - | 137.0 million | - |
| 2023-03-31 | 3.2 million | - | 50.9 million | 154.7 million |
JAGSNPHARM.NS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 472.3 million | 197.4 million |
| 2023-09-30 | 578.3 million | 209.1 million |
| 2023-06-30 | 601.5 million | 222.9 million |
| 2023-03-31 | 554.5 million | 234.0 million |
JAGSNPHARM.NS
Price: ₹357.70
52 week price:
5-year range yield:
Forward Dividend Yield: 1.40%
Payout Ratio: 53.82%
Payout Ratio Range:
Dividend Per Share: 5.00 INR
Earnings Per Share: 9.29 INR
P/E Ratio: 27.71
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 9.5 billion
Average Dividend Frequency: 1
Years Paying Dividends: 1